Guided bone regeneration procedures normally require the use of autogenous bone harvested from the intraoral area or, in the case of larger bone defects, from the iliac crest. Wherever the bone is harvested, there is a potential risk of morbidity at the donor site. This provides an argument for using alternative procedures or materials.
Growth factors either produced as recombinant growth factors or extracted from the patient are available on the market, and their use is recommended before or simultaneously with implant placement. Treatment of cancer with stem cells has been known since the early 1960s. Today extensive ongoing research focuses on the potential of stem cells to create new tissues or organs.
The lecture, on the basis of the existing literature, clarifies whether the use of growth factors or stem cells has a potential effect on the final outcome of implant therapy.
At the end of this Congress Lecture you should be able to…
recognize various sources for harvesting stem cells
describe the processes involved in tissue engineering for bone augmentation
discuss if and/or when growth factors and stem cells should be used in connection with implant therapy
ITI Online Academy Recordings, Basel, Switzerland, 2017